ArticleBMC nephrology2025
Association of iron metabolism with disease severity in acute Puumala hantavirus infection.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSerum ferritin is associated with disease severity in haemorrhagic fevers caused by various viruses, while iron has been implicated in the development of acute kidney injury (AKI). Puumala hantavirus causes a haemorrhagic fever with renal syndrome with acute kidney injury (AKI), thrombocytopenia and increased vascular leakage. Histologically acute haemorrhagic tubulointerstitial nephritis is detected. Degrading red blood cells in the kidney are an abundant source of iron and ferritin. Free iron causes oxidative stress. We aimed to evaluate the role of iron metabolism in haemorrhagic fever with renal syndrome caused by Puumala hantavirus.
methodsSerum samples from 58 patients in the acute phase and from 51/58 (88%) in the convalescence phase were analysed for variables of iron metabolism and their relationship to the disease severity of acute PUUV infection.
resultsDuring the acute phase, the median concentrations of serum ferritin (1136 vs. 225 µg/L, p < 0.001), hepcidin (386 vs. 51 ng/mL, p < 0.001), and neutrophil gelatinase-associated lipocalin (NGAL) (85 vs. 45 ng/mL, p < 0.001) were elevated, while the median concentrations of serum iron (8.4 vs. 16.2 µmol/L, p < 0.001) and transferrin (1.80 vs. 2.6 g/L, p < 0.001) were reduced compared with the convalescence phase. Serum ferritin, hepcidin, and NGAL levels correlated directly with blood leukocyte count (r = 0.307, p = 0.019; r = 0.318, p = 0.015: r = 0.761, p < 0.001), while the relationship between leukocytes and transferrin was inverse (r=-0.314, p = 0.016). Serum ferritin and hepcidin showed an inverse correlation with the minimum platelet count (r=-0.260, p = 0.048, r=-0.296, p = 0.024, respectively). However, serum ferritin, hepcidin and transferrin did not correlate with serum creatinine or NGAL.
conclusionIncreased serum ferritin and hepcidin levels, as well as decreased transferrin levels, were associated with high leukocyte counts and low platelet counts during acute PUUV infection. However, parameters of iron metabolism were not associated with the severity of AKI in this infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.